Health knowledge made personal

Cancer.gov

California 94010
The Web site of the National Cancer Institute (http://www.cancer.gov)   The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the... Full Bio
› Share page:

Posts

Sort by: Most recent | Name
Panel Reviews Benefits and Harms of CT Scans for Lung Cancer Screening by Cancer.gov Posted in: Blog Posts in Cancer A panel of experts has reviewed the evidence regarding the benefits and harms of screening for lung cancer with low-dose computed tomography (CT) and concluded that the tech ... Read on »
Lung Cancer Drug Shows Promise against Several Childhood Cancers by Cancer.gov Posted in: Blog Posts in Cancer Preliminary results from a phase I clinical trial suggest that the targeted drug crizotinib (Xalkori) may be effective in children with cancer whose tumors harbor genetic al ... Read on »
Laxative-Free CT Colonography Detects Large Polyps by Cancer.gov Posted in: Blog Posts in Cancer In a study published May 15 in the Annals of Internal Medicine, researchers found that a laxative-free CT colonography technique found a similar number of large polyps as op ... Read on »
Featured Clinical Trial: Combining Angiogenesis-Targeted Treatments for Liver Cancer by Cancer.gov Posted in: Blog Posts in Cancer The name of the trial is: Phase I/II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma (NCI-11-C-0181). Read on »
Bridging the Charles River to Find Novel Approaches to Cancer Research by Cancer.gov Posted in: Blog Posts in Cancer Dana-Farber/Harvard Cancer Center (DF/HCC) and the Massachusetts Institute of Technology's (MIT) Koch Institute for Integrative Cancer Research (Koch) recently announced the ... Read on »
Antipsychotic Drug Controls "Breakthrough" Nausea and Vomiting after Chemotherapy by Cancer.gov Posted in: Blog Posts in Cancer In a phase III clinical trial, the antipsychotic drug olanzapine (Zyprexa) was significantly more effective than metoclopramide (Reglan) in controlling chemotherapy-induced ... Read on »
U.S. Preventive Services Task Force Advises against PSA Screening by Cancer.gov Posted in: Blog Posts in Cancer A long-awaited update from the U.S. Preventive Services Task Force (USPSTF) recommends against screening men for prostate cancer with the prostate-specific antigen (PSA) tes ... Read on »
Unearthing Clues to Cancer Risk in the Aging Genome by Cancer.gov Posted in: Blog Posts in Cancer Two new studies show that some people without cancer have large, structural chromosome abnormalities in a subset of their cells, including abnormalities that have been shown ... Read on »
Sunburn and Indoor Tanning Still Common by Cancer.gov Posted in: Blog Posts in Cancer Two new reports show that young adults in the United States are engaging in behaviors that increase their risk of skin cancer. Read on »
Studies Support Expanded Role for Lenalidomide in Treating Multiple Myeloma by Cancer.gov Posted in: Blog Posts in Cancer Maintenance therapy with the drug lenalidomide (Revlimid) substantially lengthens the time patients with multiple myeloma live without their cancers progressing, according t ... Read on »
Sequencing Study Identifies Gene that May Contribute to Melanoma by Cancer.gov Posted in: Blog Posts in Cancer A whole-genome sequencing study of metastatic melanoma tumor samples has identified a gene, PREX2, that appears to be commonly mutated in melanoma and may play a role in dri ... Read on »
NIH, Industry, and Researchers Collaborate to Find New Uses for Existing Drugs by Cancer.gov Posted in: Blog Posts in Cancer NIH's National Center for Advancing Translational Sciences (NCATS) recently unveiled a collaborative program that will allow researchers to find new uses for existing drug c ... Read on »
Low-Dose Radioactive Iodine Destroys Thyroid Tissue Left after Surgery by Cancer.gov Posted in: Blog Posts in Cancer A low dose of radioactive iodine given after surgery for thyroid cancer destroyed (ablated) residual thyroid tissue as effectively as a higher dose, with fewer side effects ... Read on »
Featured Clinical Trial: Experimental Antibody for Treatment-Resistant Liver Cancer by Cancer.gov Posted in: Blog Posts in Cancer The name of the trial is TRC 105 for Liver Cancer that Has Not Responded to Sorafenib (NCI-11-C-0181). Read on »
Experimental Gene Therapy Protects Normal Cells from Toxic Effects of Chemotherapy by Cancer.gov Posted in: Blog Posts in Cancer In a proof-of-concept study, a gene therapy technique designed to protect normal blood stem cells from the toxic effects of chemotherapy allowed three patients with glioblas ... Read on »
Complex Immune-Based Cancer Treatment Shows Signs of Progress by Cancer.gov Posted in: Blog Posts in Cancer Published in Science in 2006, the results of a 15-patient clinical trial conducted by NCI researchers represented a milestone of sorts for the burgeoning field of adoptive c ... Read on »
"Rewiring" Cells to Treat an Aggressive Breast Cancer by Cancer.gov Posted in: Blog Posts in Cancer A new study suggests that learning more about how signaling pathways function in cancer cells and using this knowledge to "rewire" signaling networks could lead to novel tre ... Read on »
Women at High Risk for Breast Cancer May Benefit from Starting Mammography at Age 40 by Cancer.gov Posted in: Blog Posts in Cancer For women with twice the average risk of developing breast cancer, the benefits and harms of beginning biennial (every-other-year) screening mammography at age 40 are simila ... Read on »
Type of Surgery Affects Long-Term Survival in Early-Stage Kidney Cancer by Cancer.gov Posted in: Blog Posts in Cancer Older patients with early-stage kidney cancer lived longer if only the tumor, and not the entire kidney, was removed, according to a new study. Cancer-specific survival, how ... Read on »
The Leading Edge: Small Businesses Bring Novel Cancer Technologies to Market by Cancer.gov Posted in: Blog Posts in Cancer Eighteen companies funded by NCI’s Small Business Innovation Research (SBIR) Development Center presented the next generation of cancer therapeutics, diagnostics, and device ... Read on »